Literature DB >> 19442198

Stem cell research and therapy for liver disease.

Nalu Navarro-Alvarez1, Alejandro Soto-Gutierrez, Naoya Kobayashi.   

Abstract

Liver failure is a catastrophic illness associated with the death of many patients who are waiting for transplantation. Currently there are no effective treatments for this disease, therefore scientists have paid their attention to the field of stem cells, which has helped to understand the pathogenesis of liver disease, expanded the drug discovery processes, and could potentially be used as an alternative therapy. Recent reports demonstrating the production of liver like cells derived from bone marrow and embryonic stem cells, have established a better understanding of the soluble factors and biochemical compounds that are essential in liver development. Although considerable progress has been made in differentiating stem cells into liver cells, current protocols have not yet produced cells with the phenotype of a complete mature hepatocyte. Therefore, the proper criteria for defining what constitutes a functional human stem cell-derived hepatocyte are required. This review describes the current challenges and future opportunities in Embryonic Stem cell differentiation to liver cells, and the appropriate characteristics needed for their future clinical use in the treatment of liver disease.

Entities:  

Mesh:

Year:  2009        PMID: 19442198     DOI: 10.2174/157488809788167418

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  8 in total

Review 1.  Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets.

Authors:  Gyongyi Szabo; Fatemeh Momen-Heravi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-06-21       Impact factor: 46.802

2.  Aggregate culture of human embryonic stem cell-derived hepatocytes in suspension are an improved in vitro model for drug metabolism and toxicity testing.

Authors:  Srikumar Sengupta; Brian Patrick Johnson; Scott Allen Swanson; Ron Stewart; Christopher Alan Bradfield; James Alexander Thomson
Journal:  Toxicol Sci       Date:  2014-04-20       Impact factor: 4.849

3.  Calpain induces N-terminal truncation of β-catenin in normal murine liver development: diagnostic implications in hepatoblastomas.

Authors:  Abigale Lade; Sarangarajan Ranganathan; Jianhua Luo; Satdarshan P S Monga
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

4.  Enhanced differentiation of adult bone marrow-derived stem cells to liver lineage in aggregate culture.

Authors:  Kartik Subramanian; Derek Jason Owens; Timothy D O'Brien; Catherine M Verfaillie; Wei-Shou Hu
Journal:  Tissue Eng Part A       Date:  2011-06-30       Impact factor: 3.845

5.  Improvement of carbon tetrachloride-induced acute hepatic failure by transplantation of induced pluripotent stem cells without reprogramming factor c-Myc.

Authors:  Hua-Ming Chang; Yi-Wen Liao; Chih-Hung Chiang; Yi-Jen Chen; Ying-Hsiu Lai; Yuh-Lih Chang; Hen-Li Chen; Shaw-Yeu Jeng; Jung-Hung Hsieh; Chi-Hsien Peng; Hsin-Yang Li; Yueh Chien; Szu-Yu Chen; Liang-Kung Chen; Teh-Ia Huo
Journal:  Int J Mol Sci       Date:  2012-03-16       Impact factor: 6.208

6.  Several important in vitro improvements in the amplification, differentiation and tracing of fetal liver stem/progenitor cells.

Authors:  Wei-hui Liu; Zheng-cai Liu; Nan You; Ning Zhang; Tao Wang; Zhen-bin Gong; Hong-bao Liu; Ke-feng Dou
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

7.  Human hepatic progenitor cells express hematopoietic cell markers CD45 and CD109.

Authors:  Jun Li; Jiaojiao Xin; Liyuan Zhang; Jian Wu; Longyan Jiang; Qian Zhou; Jun Li; Jing Guo; Hongcui Cao; Lanjuan Li
Journal:  Int J Med Sci       Date:  2013-12-21       Impact factor: 3.738

8.  The role of interferon-γ inducible protein-10 in a mouse model of acute liver injury post induced pluripotent stem cells transplantation.

Authors:  Che-Chang Chan; Ling-Yi Cheng; Jean Lu; Yi-Hsiang Huang; Shih-Hwa Chiou; Ping-Hsing Tsai; Teh-Ia Huo; Han-Chieh Lin; Fa-Yauh Lee
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.